Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Revenue: $4.923B (+6.47% YoY) | Global RevPAR +3.0% | 59,100 rooms opened (371 hotels, record) | Net system growth: 7.1% | Luxury RevPAR +5.4% | Resort RevPAR +6.2% | Management/franchise fees dominant business model
InterContinental is a luxury hotel brand offering upscale accommodations and sophisticated experiences in major cities and resort destinations worldwide. The company serves affluent business and leisure travelers who expect premium amenities, exceptional service, and distinctive properties that reflect local culture and character. InterContinental has maintained its position as a leading luxury brand through iconic properties in prestigious locations, personalized concierge services, fine dining, extensive meeting facilities, and the IHG Rewards loyalty program that appeals to discerning travelers seeking elevated hospitality experiences.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.